rs35311343
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003265.3(TLR3):c.889C>G(p.Leu297Val) variant causes a missense change. The variant allele was found at a frequency of 0.00203 in 1,614,170 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 4 hom. )
Consequence
TLR3
NM_003265.3 missense
NM_003265.3 missense
Scores
2
8
9
Clinical Significance
Conservation
PhyloP100: 3.80
Publications
17 publications found
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]
TLR3 Gene-Disease associations (from GenCC):
- immunodeficiency 83, susceptibility to viral infectionsInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.035041124).
BP6
Variant 4-186082575-C-G is Benign according to our data. Variant chr4-186082575-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 495314.
BS2
High Homozygotes in GnomAdExome4 at 4 Unknown gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TLR3 | NM_003265.3 | c.889C>G | p.Leu297Val | missense_variant | Exon 4 of 5 | ENST00000296795.8 | NP_003256.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TLR3 | ENST00000296795.8 | c.889C>G | p.Leu297Val | missense_variant | Exon 4 of 5 | 1 | NM_003265.3 | ENSP00000296795.3 |
Frequencies
GnomAD3 genomes AF: 0.00167 AC: 254AN: 152194Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
254
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00148 AC: 373AN: 251348 AF XY: 0.00148 show subpopulations
GnomAD2 exomes
AF:
AC:
373
AN:
251348
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00207 AC: 3020AN: 1461858Hom.: 4 Cov.: 37 AF XY: 0.00199 AC XY: 1448AN XY: 727230 show subpopulations
GnomAD4 exome
AF:
AC:
3020
AN:
1461858
Hom.:
Cov.:
37
AF XY:
AC XY:
1448
AN XY:
727230
show subpopulations
African (AFR)
AF:
AC:
9
AN:
33480
American (AMR)
AF:
AC:
60
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
60
AN:
26134
East Asian (EAS)
AF:
AC:
1
AN:
39698
South Asian (SAS)
AF:
AC:
82
AN:
86256
European-Finnish (FIN)
AF:
AC:
64
AN:
53416
Middle Eastern (MID)
AF:
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2623
AN:
1111990
Other (OTH)
AF:
AC:
111
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
173
346
520
693
866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00167 AC: 254AN: 152312Hom.: 1 Cov.: 32 AF XY: 0.00132 AC XY: 98AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
254
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
98
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
13
AN:
41576
American (AMR)
AF:
AC:
34
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
10
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
AC:
5
AN:
10612
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
181
AN:
68028
Other (OTH)
AF:
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
12
ExAC
AF:
AC:
183
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2Other:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Susceptibility to HIV infection;C2751803:Immunodeficiency 83, susceptibility to viral infections Uncertain:1
Apr 16, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Multisystem inflammatory syndrome in children Other:1
Nov 14, 2021
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:research
- -
Immunodeficiency 83, susceptibility to viral infections Other:1
Jul 12, 2021
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;T
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.